University Of Oxford, AstraZeneca Restart COVID-19 Vaccine Trial
- September 14, 2020
Bloomberg (9/12, Baker) reported the University of Oxford and AstraZeneca “have restarted a U.K. trial of an experimental COVID-19 vaccine after it was halted over concerns about a participant who fell ill.” Bloomberg adds that while “temporary halts are common in vaccine trials, the interruption to the closely watched Astra-Oxford study had raised concerns about the viability of one of the fastest-moving experimental shots seeking protection from the pandemic.”
Also reporting were the Wall Street Journal (9/12, Loftus, Subscription Publication), the New York Times (9/12, Zimmer, Thomas, Mueller), the AP (9/12, Pylas), the Washington Post (9/12, Johnson), NPR (9/12, Palca), The Hill (9/12, Axelrod), NBC News (9/12, Suliman), and Forbes (9/12, Porterfield).